New Releases from NCBI BookshelfEnzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy (terminated appraisal).​Enzalutamide for treating non-metastatic prostate cancer after radical prostatectomy or radiotherapy (terminated appraisal).